Skip to main content
Erschienen in: Pathology & Oncology Research 2/2016

01.04.2016 | Original Article

Isolation and Characterization of a Murine Spontaneous High-Grade Follicular Lymphoma with Restricted In Vivo Spreading – a Model for Lymphatic Metastasis Via the Mesentery

verfasst von: Dóra Vojkovics, Zoltán Kellermayer, Diána Heidt, Martina Mihalj, Béla Kajtár, Dávid Ernszt, Tamás Kovács, Péter Németh, Péter Balogh

Erschienen in: Pathology & Oncology Research | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Spontaneous or induced malignant lymphomas in mice are valuable tools for studying human lymphoproliferative diseases, including the mechanism of migration between peripheral lymphoid organs and positioning within distinct tissue compartments. Here we report the isolation and characterization of a novel spontaneous lymphoma from BALB/c mice showing restricted tissue distribution and metastasis. The lymphoma cells display CD19, B220, MHC II, surface IgG2a/kappa chain with VH7183 rearrangement of the IgH gene, indicating their B-cell origin. Serial intraperitoneal injection of primary tumor into both BALB/c and RAG-1-deficient hosts led to the successful propagation of lymphoma. Despite the cytological characteristics of high-grade follicular B-cell lymphoma, the tumor cells (denoted as Bc-DLFL.1) showed significantly lesser spreading to extraabdominal locations upon intraperitoneal passage compared to splenic and mesenteric lymph node expansion. In mesenteric lymph nodes the high endothelial venules contained only few tumor cells, while the lymphatic vessels were almost completely filled with lymphoma cells. Similarly, the LYVE-1-positive lymphatic capillaries within the mesentery were packed with lymphoma cells. These findings suggest that Bc-DLFL.1 cells likely propagate primarily via the lymphatic circulation within the mesentery, therefore this tumor may offer an in vivo model to investigate the tumor cell migration via the lymphatic circulation from the peritoneal cavity.
Literatur
1.
Zurück zum Zitat Deshpande AJ, Buske C, Quintanilla-Martinez L, Fend F (2010) In: Dunphy CH (ed) Molecular oncogenesis in Molecular pathology of hematolymphoid diseases. Springer, New York Dordrecht Heidelberg London, pp. 3–21CrossRef Deshpande AJ, Buske C, Quintanilla-Martinez L, Fend F (2010) In: Dunphy CH (ed) Molecular oncogenesis in Molecular pathology of hematolymphoid diseases. Springer, New York Dordrecht Heidelberg London, pp. 3–21CrossRef
2.
Zurück zum Zitat Morse HC 3rd , Anver MR, Fredrickson TN, Haines DC, Harris AW, Harris NL, Jaffe ES, Kogan SC, MacLennan IC, Pattengale PK, Ward JM (2002) Hematopathology subcommittee of the mouse models of human cancers consortium. Bethesda Proposals for Classification of Lymphoid Neoplasms in Mice Blood 100:246–258. Morse HC 3rd , Anver MR, Fredrickson TN, Haines DC, Harris AW, Harris NL, Jaffe ES, Kogan SC, MacLennan IC, Pattengale PK, Ward JM (2002) Hematopathology subcommittee of the mouse models of human cancers consortium. Bethesda Proposals for Classification of Lymphoid Neoplasms in Mice Blood 100:246–258.
4.
Zurück zum Zitat Kovalchuk AL, Qi CF, Torrey TA, Taddesse-Heath L, Feigenbaum L, Park SS, Gerbitz A, Klobeck G, Hoertnagel K, Polack A, Bornkamm GW, Janz S, Morse HC 3rd (2000) Burkitt lymphoma in the mouse. J Exp Med 192:1183–1190 Kovalchuk AL, Qi CF, Torrey TA, Taddesse-Heath L, Feigenbaum L, Park SS, Gerbitz A, Klobeck G, Hoertnagel K, Polack A, Bornkamm GW, Janz S, Morse HC 3rd (2000) Burkitt lymphoma in the mouse. J Exp Med 192:1183–1190
5.
Zurück zum Zitat Strasser A, Harris AW, Vaux DL, Webb E, Bath ML, Adams JM, Cory S (1990) Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr Top Microbiol Immunol 166:175–181PubMed Strasser A, Harris AW, Vaux DL, Webb E, Bath ML, Adams JM, Cory S (1990) Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr Top Microbiol Immunol 166:175–181PubMed
6.
Zurück zum Zitat Egle A, Harris AW, Bath ML, O’Reilly L, Cory S (2004) VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. Blood 103:2276–2283CrossRefPubMed Egle A, Harris AW, Bath ML, O’Reilly L, Cory S (2004) VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. Blood 103:2276–2283CrossRefPubMed
7.
Zurück zum Zitat Balogh P, Lábadi P (2011) Structural evolution of the spleen in man and mouse in developmental biology of peripheral lymphoid organs Ed. P. Balogh springer-verlag. Berlin Heidelberg 2011:121–142 Balogh P, Lábadi P (2011) Structural evolution of the spleen in man and mouse in developmental biology of peripheral lymphoid organs Ed. P. Balogh springer-verlag. Berlin Heidelberg 2011:121–142
8.
Zurück zum Zitat Kim HJ, Kammertoens T, Janke M, Schmetzer O, Qin Z, Berek C, Blankenstein T (2004) Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells. J Immunol 172:4037–4047CrossRefPubMed Kim HJ, Kammertoens T, Janke M, Schmetzer O, Qin Z, Berek C, Blankenstein T (2004) Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells. J Immunol 172:4037–4047CrossRefPubMed
9.
Zurück zum Zitat Höpken UE, Rehm A (2012) Homeostatic chemokines guide lymphoma cells to tumor growth-promoting niches within secondary lymphoid organs. J Mol Med (Berl) 90:1237–1245CrossRef Höpken UE, Rehm A (2012) Homeostatic chemokines guide lymphoma cells to tumor growth-promoting niches within secondary lymphoid organs. J Mol Med (Berl) 90:1237–1245CrossRef
10.
Zurück zum Zitat Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE (1992) RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869–877CrossRefPubMed Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE (1992) RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869–877CrossRefPubMed
11.
Zurück zum Zitat Cobaleda C, Jochum W, Busslinger M (2007) Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 449:473–477CrossRefPubMed Cobaleda C, Jochum W, Busslinger M (2007) Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 449:473–477CrossRefPubMed
12.
Zurück zum Zitat Frith CG, Wiley LD (1981) Morphologic classification and correlation of incidence of hyperplastic and neoplastic hematopoietic lesions in mice with age. J Gerontol 36:534–545CrossRefPubMed Frith CG, Wiley LD (1981) Morphologic classification and correlation of incidence of hyperplastic and neoplastic hematopoietic lesions in mice with age. J Gerontol 36:534–545CrossRefPubMed
13.
Zurück zum Zitat Bunting KL, Melnick AM (2013) New effector functions and regulatory mechanisms of BCL6 in normal and malignant lymphocytes. Curr Opin Immunol 25:339–346CrossRefPubMedPubMedCentral Bunting KL, Melnick AM (2013) New effector functions and regulatory mechanisms of BCL6 in normal and malignant lymphocytes. Curr Opin Immunol 25:339–346CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Basso K, Dalla-Favera R (2012) Roles of BCL6 in normal and transformed germinal center B cells. Immunol Rev 247:172–183CrossRefPubMed Basso K, Dalla-Favera R (2012) Roles of BCL6 in normal and transformed germinal center B cells. Immunol Rev 247:172–183CrossRefPubMed
15.
Zurück zum Zitat Johnston CM, Wood AL, Bolland DJ, Corcoran AE (2006) Complete sequence assembly and characterization of the C57BL/6 mouse Ig heavy chain V region. J Immunol 176:4221–4234CrossRefPubMed Johnston CM, Wood AL, Bolland DJ, Corcoran AE (2006) Complete sequence assembly and characterization of the C57BL/6 mouse Ig heavy chain V region. J Immunol 176:4221–4234CrossRefPubMed
16.
Zurück zum Zitat Fu YX, Huang G, Wang Y, Chaplin DD (1998) B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin alpha-dependent fashion. J Exp Med 187:1009–1018CrossRefPubMedPubMedCentral Fu YX, Huang G, Wang Y, Chaplin DD (1998) B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin alpha-dependent fashion. J Exp Med 187:1009–1018CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Förster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M (1996) A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87:1037–1047CrossRefPubMed Förster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M (1996) A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87:1037–1047CrossRefPubMed
18.
Zurück zum Zitat Ansel KM, Ngo VN, Hyman PL, Luther SA, Förster R, Sedgwick JD, Browning JL, Lipp M, Cyster JG (2000) A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406:309–314CrossRefPubMed Ansel KM, Ngo VN, Hyman PL, Luther SA, Förster R, Sedgwick JD, Browning JL, Lipp M, Cyster JG (2000) A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406:309–314CrossRefPubMed
19.
Zurück zum Zitat Rosen SD (2004) Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol 22:129–156CrossRefPubMed Rosen SD (2004) Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol 22:129–156CrossRefPubMed
20.
Zurück zum Zitat Mahadevan A, Welsh IC, Sivakumar A, Gludish DW, Shilvock AR, Noden DM, Huss D, Lansford R, Kurpios NA (2014) The left-right Pitx2 pathway drives organ-specific arterial and lymphatic development in the intestine. Dev Cell 31:690–706CrossRefPubMedPubMedCentral Mahadevan A, Welsh IC, Sivakumar A, Gludish DW, Shilvock AR, Noden DM, Huss D, Lansford R, Kurpios NA (2014) The left-right Pitx2 pathway drives organ-specific arterial and lymphatic development in the intestine. Dev Cell 31:690–706CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Ansel KM, Harris RB, Cyster JG (2002) CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 16:67–76CrossRefPubMed Ansel KM, Harris RB, Cyster JG (2002) CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 16:67–76CrossRefPubMed
22.
Zurück zum Zitat Berberich S, Dähne S, Schippers A, Peters T, Müller W, Kremmer E, Förster R, Pabst O (2008) Differential molecular and anatomical basis for B cell migration into the peritoneal cavity and omental milky spots. J Immunol 180:2196–2203CrossRefPubMed Berberich S, Dähne S, Schippers A, Peters T, Müller W, Kremmer E, Förster R, Pabst O (2008) Differential molecular and anatomical basis for B cell migration into the peritoneal cavity and omental milky spots. J Immunol 180:2196–2203CrossRefPubMed
23.
Zurück zum Zitat Gashev AA (2010) Basic mechanisms controlling lymph transport in the mesenteric lymphatic net. Ann N Y Acad Sci 1207(Suppl 1):E16–E20CrossRefPubMed Gashev AA (2010) Basic mechanisms controlling lymph transport in the mesenteric lymphatic net. Ann N Y Acad Sci 1207(Suppl 1):E16–E20CrossRefPubMed
24.
Zurück zum Zitat Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, Furusawa J, Ohtani M, Fujii H, Koyasu S (2010) Innate production of T(H)2 cytokines by adipose tissue-associated c-kit(+)Sca-1(+) lymphoid cells. Nature 463:540–544CrossRefPubMed Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, Furusawa J, Ohtani M, Fujii H, Koyasu S (2010) Innate production of T(H)2 cytokines by adipose tissue-associated c-kit(+)Sca-1(+) lymphoid cells. Nature 463:540–544CrossRefPubMed
25.
Zurück zum Zitat Braun A, Worbs T, Moschovakis GL, Halle S, Hoffmann K, Bölter J, Münk A, Förster R (2011) Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration. Nat Immunol 12:879–887CrossRefPubMed Braun A, Worbs T, Moschovakis GL, Halle S, Hoffmann K, Bölter J, Münk A, Förster R (2011) Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration. Nat Immunol 12:879–887CrossRefPubMed
26.
Zurück zum Zitat Förster R, Braun A, Worbs T (2012) Lymph node homing of T cells and dendritic cells via afferent lymphatics. Trends Immunol 33:271–280CrossRefPubMed Förster R, Braun A, Worbs T (2012) Lymph node homing of T cells and dendritic cells via afferent lymphatics. Trends Immunol 33:271–280CrossRefPubMed
27.
Zurück zum Zitat Miller CN, Hartigan-O’Connor DJ, Lee MS, Laidlaw G, Cornelissen IP, Matloubian M, Coughlin SR, McDonald DM, McCune JM (2013) IL-7 production in murine lymphatic endothelial cells and induction in the setting of peripheral lymphopenia. Int Immunol 25:471–483CrossRefPubMedPubMedCentral Miller CN, Hartigan-O’Connor DJ, Lee MS, Laidlaw G, Cornelissen IP, Matloubian M, Coughlin SR, McDonald DM, McCune JM (2013) IL-7 production in murine lymphatic endothelial cells and induction in the setting of peripheral lymphopenia. Int Immunol 25:471–483CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Muppidi JR, Schmitz R, Green JA, Xiao W, Larsen AB, Braun SE, An J, Xu Y, Rosenwald A, Ott G, Gascoyne RD, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Vaidehi N, Staudt LM, Cyster JG (2014) Loss of signalling via Gα13 in germinal Centre B-cell-derived lymphoma. Nature 516:254–258CrossRefPubMedPubMedCentral Muppidi JR, Schmitz R, Green JA, Xiao W, Larsen AB, Braun SE, An J, Xu Y, Rosenwald A, Ott G, Gascoyne RD, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Vaidehi N, Staudt LM, Cyster JG (2014) Loss of signalling via Gα13 in germinal Centre B-cell-derived lymphoma. Nature 516:254–258CrossRefPubMedPubMedCentral
Metadaten
Titel
Isolation and Characterization of a Murine Spontaneous High-Grade Follicular Lymphoma with Restricted In Vivo Spreading – a Model for Lymphatic Metastasis Via the Mesentery
verfasst von
Dóra Vojkovics
Zoltán Kellermayer
Diána Heidt
Martina Mihalj
Béla Kajtár
Dávid Ernszt
Tamás Kovács
Péter Németh
Péter Balogh
Publikationsdatum
01.04.2016
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 2/2016
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-015-0025-6

Weitere Artikel der Ausgabe 2/2016

Pathology & Oncology Research 2/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.